Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
about
Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent mannerRegulation of gene expression in osteoblasts.Histone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcriptionLevetiracetam, phenytoin, and valproate act differently on rat bone mass, structure, and metabolism.Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors.Direct comparison of human mesenchymal stem cells derived from adipose tissues and bone marrow in mediating neovascularization in response to vascular ischemia.Intermittent activation of notch signaling promotes bone formation.Ethyl-3,4-dihydroxybenzoate with a dual function of induction of osteogenic differentiation and inhibition of osteoclast differentiation for bone tissue engineering.Zinc finger protein 467 is a novel regulator of osteoblast and adipocyte commitment.Histone deacetylases in skeletal development and bone mass maintenance.The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone lossModification of histone acetylation facilitates hepatic differentiation of human bone marrow mesenchymal stem cells.Suberoylanilide hydroxamic acid (SAHA; vorinostat) causes bone loss by inhibiting immature osteoblasts.Adipose-derived stem cells in functional bone tissue engineering: lessons from bone mechanobiology.In Vitro and In Vivo Osteogenic Activity of Largazole.Deleterious effects of freezing on osteogenic differentiation of human adipose-derived stromal cells in vitro and in vivo.Human adipose-derived stromal cells stimulate autogenous skeletal repair via paracrine Hedgehog signaling with calvarial osteoblasts.Mesenchymal stem cells primed with valproate and lithium robustly migrate to infarcted regions and facilitate recovery in a stroke model.Hdac-mediated control of endochondral and intramembranous ossificationA Novel Osteogenic Activity of Suberoylanilide Hydroxamic Acid is Synergized by BMP-2.Signaling networks that control the lineage commitment and differentiation of bone cells.Exposure to valproic acid inhibits chondrogenesis and osteogenesis in mid-organogenesis mouse limbs.Signaling and transcriptional regulation in osteoblast commitment and differentiationEpigenetic Mechanisms Regulating Mesenchymal Stem Cell Differentiation.Chromatin condensation in terminally differentiating mouse erythroblasts does not involve special architectural proteins but depends on histone deacetylation.Osteogenic differentiation of mesenchymal stem cells promoted by overexpression of connective tissue growth factor.Antiepileptic drug use and rates of hip bone loss in older men: a prospective study.The epigenetics of adult (somatic) stem cells.Mecp2 deficiency decreases bone formation and reduces bone volume in a rodent model of Rett syndrome.Osteogenic potential of adult stem cells from human maxillary sinus membrane by Simvastatin in vitro: preliminary report.Inhibition of histone deacetylase activity in reduced oxygen environment enhances the osteogenesis of mouse adipose-derived stromal cellsHDACi: cellular effects, opportunities for restorative dentistry.Double edge: CDK2AP1 in cell-cycle regulation and epigenetic regulation.Panobinostat for the treatment of multiple myeloma.Epigenetic modulation of dental pulp stem cells: implications for regenerative endodontics.Dynamic and distinct histone modifications of osteogenic genes during osteogenic differentiation.Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo.Osteogenic potential: Comparison between bone marrow and adipose-derived mesenchymal stem cells.Bone marrow-derived stem/stromal cells and adipose tissue-derived stem/stromal cells: Their comparative efficacies and synergistic effects.HDAC inhibitor trichostatin A suppresses osteoclastogenesis by upregulating the expression of C/EBP-β and MKP-1.
P2860
Q24300259-05D359C7-9ABD-4D63-9EA6-C90B0F28C88AQ27691363-C9C12A5D-A3E7-43AC-8EE6-D7BCD25804E7Q28505369-E836B874-6708-4393-973D-57399ACFC192Q33290977-DBA6B425-D5FA-401D-8DAF-6A7973701F59Q33302058-212ACB01-C969-4C71-9510-5B1A4B7FC1DEQ33304976-F46E2A72-1429-47CB-A77C-F69AD26B2F8CQ33850283-2742B487-76D7-4FC8-AF20-20934656E405Q34500583-A1F5190F-64E8-48AF-87EA-CD6EFC821B1BQ34575607-995C149E-E30E-4EF7-B38E-6F9D94426431Q34612849-6F46B9CF-5AAA-45C2-97ED-0329F3A04503Q34686787-9A7173F6-5BAE-48C7-858D-DFE1996199B7Q34713160-13EEAE11-F1AA-469A-8FEF-141F2991B2A9Q34810920-0C780E4F-1948-4521-89E6-C4FEEDADDD8FQ34995652-6886C4DE-E015-41B6-AD45-C32131B42CF5Q35030533-70671219-342E-471B-9A3B-BA19C5B94873Q35084118-E9D9D0C1-807D-4A4C-B55D-02493F5B0628Q35084126-7B1C14CF-6531-4748-B5CD-5A84E3A4CB3EQ35243356-B7AA8DCE-0C6A-445D-B47A-BD0296C70891Q35556841-1BABB733-C860-4003-87A0-2E163F23E67FQ35739595-BFB69538-44A2-407E-A84D-A496FB9CFFF5Q36082866-7C1721BF-C650-45E6-960A-E8785C3C64DFQ36509064-4C25F9DC-46D0-43AE-9F6B-322E5CBA998DQ36606452-6A4B8B49-3BE1-4ED2-A730-AFC84FA79017Q36613056-7B56A391-AB25-4FE3-B277-511E587015FDQ37155979-D9AE6EC1-9349-4CA1-B83A-82CD31AE3DDDQ37177471-A9B7D62B-54D1-423F-B8F5-93FD9B961059Q37178973-FE756AA2-A1E2-4363-A3BE-B1162E9A9C95Q37186709-B75A7920-3202-4DAE-B82A-5A5D69217110Q37335897-44691409-6468-47E0-A19A-2A0679BC5B33Q37380589-7DD6DF85-21DC-4EC1-82C3-1F0BE954C695Q37471517-51F3C584-6597-4F88-B452-EA60D390ACB0Q37871246-2522D7E0-7ED6-4EE1-9930-99B14C3A81A2Q37921992-36720905-E488-4F74-BCD4-624B92006DEDQ37992104-AF2C0475-EDE3-43A2-881F-BC26A79F82B5Q38502939-6BF2A475-2BBD-4E58-8DF4-4C58CF37F7BCQ38863680-7A3120D1-AC66-4F92-8183-539B4892AE88Q39020389-9CD75C20-4E2B-4EFE-9D45-20536B7FB0AEQ39144554-2401FAA9-A948-4918-9F68-F9053EA51422Q39248693-8FC10416-85C5-463C-80B6-006A99EB0C2AQ39427988-A916C60A-49B7-4B90-ACA1-16CC673E8F3E
P2860
Induction of osteogenic differentiation of human mesenchymal stem cells by histone deacetylase inhibitors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Induction of osteogenic differ ...... istone deacetylase inhibitors.
@en
Induction of osteogenic differ ...... istone deacetylase inhibitors.
@nl
type
label
Induction of osteogenic differ ...... istone deacetylase inhibitors.
@en
Induction of osteogenic differ ...... istone deacetylase inhibitors.
@nl
prefLabel
Induction of osteogenic differ ...... istone deacetylase inhibitors.
@en
Induction of osteogenic differ ...... istone deacetylase inhibitors.
@nl
P2093
P356
P1476
Induction of osteogenic differ ...... istone deacetylase inhibitors.
@en
P2093
Hyun Hwa Cho
Hyung Taek Park
Jin Sup Jung
Kuen Taek Suh
Yeon Jeong Kim
Yong Chan Bae
P304
P356
10.1002/JCB.20544
P577
2005-10-01T00:00:00Z